Pharmaceutical Patent Infringement and the Specific Mechanism – Merck Canada Inc and Merck Sharp & Dohme Ltd v Sigma Pharmaceuticals Plc [2012] EWPCC18
The following summarises another interesting decision for the rejuvenated Patents County Court which is continuing to flourish as a forum for smaller intellectual property disputes of all kinds. Merck is the proprietor of European Patent (EP (UK) 1 480 717) which, in relation to the product montelukast (Singulair, used for the treatment of adult and…